Programme
DAY 1 - June 30, 2022
Registration opening
8H30Opening
9H15Keynote Lecture
Charles Swanton – Cancer evolution, immune evasion and metastasis
9H15Morning Session: Single-Cell RNA-Seq & Spatial Resolution (Part 1/2)
10H10 - Charles-Antoine Dutertre – Heterogenity of Tumor - Associated Macrophages
10H35 - Coffee Break
11H05 - Fatima Mechta-Grigoriou – Single cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer
11H30 - Lucas Blanchard – High endothelial venules: specialized blood vessels for lymphocyte entry into tumors
10H10Lunch Break
11H55Symposium Miltenyi Biotec
12H15 - 13H45Afternoon session: Single-Cell RNA-Seq & Spatial Resolution (Part 2/2)
14H00 - Drew Pardoll – T cells in non-small lung cancer
14H25 - Celine Vallot – Multi-omics single cell analysis of TNBC
14H50 - Eliane Piaggio – Immune landscape of rhabdoid tumors: non-genetic mechanisms of tumor immunogenicity
15H15 - Coffee Break
15H45 - Wolf Hervé Fridman - Shaping of B cell immunity in the tumor microenvironment
16H10 - Julie Helft - Macrophage subsets and T cell immunity in breast cancer
16H35 - Jennifer Wargo – The role of the gut and tumor microbiome in cancer
14H00Gala Dinner
Bateaux Parisiens
Port de la Bourdonnais, ponton 5 bis
19H30DAY 2 – July 1, 2022
Morning session: Novel Omics And Integration
9H30 - Diether Lambrechts – Single-cell profiling of the tumor microenvironment during checkpoint immunotherapy
9H55 - Aymeric Silvin – Dual ontogeny of disease-associated microglia and disease inflammatory macrophages in ageing and neurodegeneration
10H20 - Coffee Break
10H50 - Nicolas A Giraldo – Multispectral, multispatial UMAP analysis.
11H15 - Etienne Becht – Spatial transcriptomic analysis of the adaptive immune response to tumors
11H40 - Theo Hirsch – Cell plasticity and cisplatin resistance in hepatoblastoma
9H30Lunch Break
12H05Afternoon session: cancer, microbiome and virome
14H00 - Abstract n°1 - Cecile Alanio – Immune evolution of glioblastoma tumors under combination of EGFRvIII CAR T cells and anti-PD1 therapies
14H20 - Abstract n°2 - Wei Xie – Role of apoptotic executioner caspase 3/7 in intestinal inflammation
14H40 - Abstract n°3 - Emese Zsiros – Multi-omics approach unveils etiology underlying recurrent ovarian cancer patient response to anti-PD1 combination therapy
15H00 - Andrew Maltez Thomas – A multi-cohort view of the gut microbiome in cancer
15H25 - Coffee Break
15H55 - Laurence Zitvogel – Microbiota-centered interventions for next-generation IO
16H20 - Maria Rescigno – The microbiota in colorectal cancer metastases formation
14H00